Medline Inc.

Medline Inc.

MDLN

Get informed when a big investor buys or sells

+ Follow
Market Cap$33.22B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Medline Inc.Medline Inc.32.5-9%1.21.1
$44.00

Target Price by Analysts

4.7% upsideMedline Target Price DetailsTarget Price
$50.75

Current Fair Value

20.7% upside

Undervalued by 20.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$33.22 Billion
Enterprise Value$43.55 Billion
Dividend Yield$- (-)
Earnings per Share$1.43
Beta-0.42
Outstanding Shares819,000,000

Return

Return on Equity8.55%ROE
Return on Assets2.47%
Return on Invested Capital5.52%

Valuation & Multiples

P/E Ratio32.46P/E Ratio
PEG-53.94PEG
Price to Sales1.2Price to Sales
Price to Book Ratio1.83Price to Book Ratio
Enterprise Value to Revenue1.49
Enterprise Value to EBIT21.65
Enterprise Value to Net Income45
Total Debt to Enterprise0.29
Debt to Equity1.12Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
June 3, 2026
EPS Estimate
$0.29
Average shareholder expectation
Revenue Estimate
$7.13 B
Average shareholder expectation

Next Earnings Call

Expected Date
August 5, 2026
EPS Estimate
$0.32
Average shareholder expectation
Revenue Estimate
$7.51 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 38.79%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.99% 74.42%
Total Invested$1.29B 95.45%
Investors Holding104 224.00%

ESG Score

No data

About Medline Inc.

43,000 employees
CEO: James Boyle

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medli...